BioHealth News Archive
FIRST PATIENT DOSED IN AVDORALIMAB PHASE II CLINICAL TRIAL IN COVID-19 PATIENTS WITH SEVERE PNEUMONIA
Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the first patient was dosed in…
Read More
Risks and Implications of Post Hoc Changes to the Borrower Certification Requirements: What PPP Borrowers Need to Know | Insights | Venable LLP
Since the enactment of the CARES Act, the Small Business Administration and U.S. Department of the Treasury have continually updated the rules governing the…
Read More
NIH mobilizes national innovation initiative for COVID-19 diagnostics
The National Institutes of Health today announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component…
Read More
NIAID: Gilead’s Remdesivir Shows Positive Proof of Concept in Hospitalized COVID-19 Patients
Gilead Sciences’ closely-watched COVID-19 drug candidate remdesivir outperformed placebo in a clinical trial sponsored by the NIH’s National Institute of Allergy and Infectious Disease…
Read More
Gilson and QIAGEN Announce Collaboration Aiming to Make Manual Nucleic Acid Extraction More Efficient and Reproducible
Gilson and QIAGEN have entered into a strategic partnership that will provide researchers the ability to limit operator-dependent variation in their manual nucleic acid…
Read More
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic | TechCrunch
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from…
Read More
Personal Genome Diagnostics Receives FDA Clearance for PGDx elio™ tissue complete, the First Comprehensive Genomic Profiling Diagnostic Kit for Oncology | Business Wire
BALTIMORE--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, announced today that the company has received market clearance from the U.S. Food…
Read More
LifeSprout, Inc. Closes $28.5 Million Series A Financing
BALTIMORE, Md., April 27, 2020 /PRNewswire/ -- LifeSprout, a privately-held regenerative medicine company founded with technology licensed from Johns Hopkins University, has closed a $28.5…
Read More
Gentian AS Seeking Collaborator to Test BioMarker Performance in Severe COVID-19 Cases
Gentian AS, a Norwegian company, with its US office at BioHealth Innovation in Rockville, Maryland is seeking collaborators to investigate if two of the…
Read More
Hard to Find Small Lab Space – Only Two Spaces Left! – Alexandria LaunchLabs™
Alexandria LaunchLabs™ in Maryland, will provide fully equipped, affordable laboratory/office space with flexible lease terms, supporting infrastructure, access to amenities, and supporting services and…
Read More
Innara Health and BHI Partner to Accelerate Company Growth
FDA Cleared Medical Device Improves Feeding Outcomes of Infants Born Prematurely Olathe, KS and Rockville, MD, April 28, 2020—Innara Health, developer of the only…
Read More
Governor Hogan Introduces Safe, Gradual, and Effective ‘Maryland Strong: Roadmap to Recovery’
ANNAPOLIS, MD—After weeks of consulting with leading scientists, business leaders, and public health experts, Governor Larry Hogan today introduced the ‘Maryland Strong: Roadmap to Recovery,’ which…
Read MoreFive takeaways from Gov. Larry Hogan’s plan to reopen Maryland – Baltimore Sun
Maryland Gov. Larry Hogan on Friday announced his three-phase plan to eventually reopen the state amid the coronavirus pandemic. Hogan called the plan a…
Read More
This physician-founder is making a device to protect medical staff during intubation procedures – Technical.ly Baltimore
Working as an emergency and critical care physician at the University of Maryland School of Medicine, Dr. Steven Tropello is seeing the lack of…
Read More
Emergex Signs Agreement with GEORGE MASON UNIVERSITY for Highly Pathogenic RNA Virus Studies
Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered…
Read More